PARP inhibitors (poly ADP-ribose polymerase inhibitors). It is a type of targeted cancer therapy and an antineoplastic agent.
Generic Name:
Olaparib
Indication:
For:
Treatment of certain types of ovarian, breast, pancreatic, and prostate cancers, often in patients with specific genetic mutations (such as BRCA1/2) or homologous recombination repair (HRR) gene mutations.
Supplied as:
Tablet:
150mg 60s
Disclaimer:
Please consult your doctor before taking any medicine. To be sold only on prescription.